Makoto Fujimoto Selected Research

keishibukuryogan

1/2015	Effect of keishibukuryogan on genetic and dietary obesity models.
1/2012	Effect of keishibukuryogan on endothelial function in patients with at least one component of the diagnostic criteria for metabolic syndrome: a controlled clinical trial with crossover design.
1/2011	Keishibukuryogan reduces renal injury in the early stage of renal failure in the remnant kidney model.
3/2010	The traditional Japanese formula keishibukuryogan reduces liver injury and inflammation in patients with nonalcoholic fatty liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Makoto Fujimoto Research Topics

Disease

11	Non-alcoholic Fatty Liver Disease 03/2014 - 10/2006
10	Obesity 01/2021 - 02/2008
6	Inflammation (Inflammations) 09/2014 - 02/2008
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2016 - 03/2010
4	Neoplasms (Cancer) 04/2021 - 03/2014
4	Fatty Liver 09/2014 - 10/2006
4	Fibrosis (Cirrhosis) 09/2014 - 10/2006
3	Drug-Related Side Effects and Adverse Reactions 01/2019 - 12/2017
3	Hepatocellular Carcinoma (Hepatoma) 05/2018 - 12/2008
3	Type 2 Diabetes Mellitus (MODY) 11/2016 - 02/2008
3	Hyperlipidemias (Hyperlipidemia) 03/2014 - 01/2011
3	Alcoholic Fatty Liver 09/2012 - 03/2008
3	Body Weight (Weight, Body) 03/2010 - 10/2006
2	Carcinogenesis 09/2014 - 01/2012
2	Abdominal Obesity 03/2014 - 02/2008
1	Neoplasm Metastasis (Metastasis) 04/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Breast Neoplasms (Breast Cancer) 03/2019
1	Lung Injury 01/2019
1	Drug Eruptions (Drug Eruption) 01/2019
1	Chemical and Drug Induced Liver Injury 06/2018
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2017
1	Hypertension (High Blood Pressure) 04/2016
1	Chronic Renal Insufficiency 04/2016
1	Human Influenza (Influenza) 01/2013
1	Insulin Resistance 01/2012
1	Hyperemia 01/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2011
1	Pressure Ulcer (Bedsore) 01/2011
1	Renal Insufficiency (Renal Failure) 01/2011
1	Skin Ulcer 01/2011
1	Hyperphagia (Overeating) 09/2009
1	Morbid Obesity 09/2009
1	Diabetes Mellitus 09/2009
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2008

Drug/Important Bio-Agent (IBA)

7	Sodium Glutamate (Accent)IBA 09/2014 - 02/2008
4	keishibukuryoganIBA 01/2015 - 03/2010
3	Pharmaceutical PreparationsIBA 03/2019 - 12/2017
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2012
2	Messenger RNA (mRNA)IBA 05/2018 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 05/2018 - 01/2012
2	Glucose (Dextrose)FDA LinkGeneric 09/2014 - 03/2008
2	LipidsIBA 03/2014 - 03/2008
2	Galectin 3 (LGALS3)IBA 01/2012 - 12/2008
2	CholesterolIBA 03/2010 - 10/2006
1	MAP Kinase Kinase Kinase 5IBA 04/2021
1	Interferon-gamma (Interferon, gamma)IBA 04/2021
1	shikoninIBA 03/2019
1	Ephedrae herbaIBA 01/2019
1	EnzymesIBA 05/2018
1	Glutamate-Ammonia Ligase (Glutamine Synthetase)IBA 05/2018
1	Cholic AcidIBA 05/2018
1	Betaine (C.B.B.)FDA Link 05/2018
1	Bile Acids and Salts (Bile Acids)IBA 05/2018
1	Taurocholic Acid (Sodium Taurocholate)IBA 05/2018
1	IronIBA 11/2016
1	Antihypertensive Agents (Antihypertensives)IBA 04/2016
1	juzentaihotoIBA 01/2013
1	Pioglitazone (Actos)FDA Link 09/2012
1	Lipid PeroxidesIBA 09/2012
1	LeptinIBA 09/2012
1	LipopolysaccharidesIBA 01/2012
1	Lovastatin (Mevacor)FDA LinkGeneric 01/2012
1	Malondialdehyde (Propanedial)IBA 01/2012
1	Choline (Choline Chloride)IBA 01/2012
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2012
1	Amino Acids FDA Link 01/2012
1	red yeast riceIBA 01/2012
1	CDAA (Randox)IBA 01/2012
1	Nonesterified Fatty Acids (NEFA)IBA 01/2012
1	Oxygen (Dioxygen)IBA 01/2011
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2011
1	kamikihi-to (KKT)IBA 01/2011
1	CytokinesIBA 01/2011
1	Fibronectins (Fibronectin)IBA 01/2011
1	AdipokinesIBA 03/2008
1	Insulin (Novolin)FDA Link 10/2006

Therapy/Procedure

8	Kampo Medicine (Kampo) 01/2019 - 03/2008
1	Immunotherapy 04/2021
1	Therapeutics 04/2021
1	Medication Errors (Medication Error) 12/2017
1	Diet Therapy (Therapy, Diet) 03/2014
1	Subcutaneous Injections 09/2012
1	Nephrectomy 01/2011